Skip to content

Clinical trials

Coronary Artery Disease trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Country / region: Saudi Arabia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20122
20131
20143
20161
20171
20202
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Saud Al Babtain Cardiac Center2
Abbott Medical Devices1
AstraZeneca1
ECRI bv1
Elixir Medical Corporation1
Gilbert L. Raff, MD1
Imam Abdulrahman Bin Faisal University1
Imperial College London1
Kafrelsheikh University1
Medtronic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease16
Cardiovascular Diseases3
Chest Pain2
Diabetes Mellitus2
Heart Diseases2
Acute Coronary Syndrome1
Angina Pectoris1
Aortic Aneurysm1
Coronary Disease1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.